Lv3
270 积分 2024-07-19 加入
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease
21天前
已完结
Clinical outcomes and 30-day readmissions associated with high-output heart failure
21天前
已完结
In-Hospital and readmission outcomes of patients with myeloproliferative neoplasms and heart failure: Insights from the National Readmissions Database
21天前
已完结
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights
21天前
已完结
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’
30天前
已关闭
The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
30天前
已完结
Cardiovascular risk in a contemporary cohort of patients with myeloproliferative neoplasms’
30天前
已完结
Thrombosis in myeloproliferative neoplasms: update in pathophysiology
1个月前
已完结
Optimization of cardiovascular risk factor management in patients with BCR::ABL1 negative chronic myeloproliferative neoplasms, current knowledge, and perspectives
1个月前
已完结
Myeloproliferative Neoplasms and Cardiovascular Disease: A Review
1个月前
已完结
皖公网安备34019202002308
